A regulatory polymorphism in promoter region of TNFR1 gene is associated with Kawasaki disease in Chinese individuals

Human Immunology

Volumn 72, Issue 5, 2011, Pages 451-457

  Wang, Guo Bing ^a   Li, Cheng Rong ^a   Yang, Jun ^a   Wen, Peng Qiang ^a   Jia, Shi Lei ^a  

^a SHENZHEN CHILDREN'S HOSPITAL   (China)

Author keywords

Chinese; Kawasaki disease; Polymorphism; Regulatory; Tumor necrosis factor receptor superfamily member 1A

Indexed keywords

ALLELE; ARTICLE; BIOINFORMATICS; CHILD; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 1 GENE;

CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTIONAL ACTIVATION;

EID: 79954626120     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.004     Document Type: Article

References (32)

1. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004, 110:2747-2771.
2. Lang B.A., Silverman E.D., Laxer R.M., Lau A.S. Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989, 115:939-943.
3. Eberhard B.A., Andersson U., Laxer R.M., Rose V., Silverman E.D. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995, 14:199-203.
4. Hui-Yuen J.S., Duong T.T., Yeung R.S. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006, 176:6294-6301.
5. Stringer E., Yeung R.S. Pathogenesis of Kawasaki disease: The central role of TNF-α. Future Rheumatol 2008, 3:69-77.
6. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 2003, 3:745-756.
7. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001, 104:487-501.
8. MacEwan D.J. TNF receptor subtype signalling: Differences and cellular consequences. Cell Signal 2002, 14:477-492.
9. Kurt A.N., Aygun A.D., Godekmerdan A., Kurt A., Dogan Y., Yilmaz E. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediat Inflamm 2007, 31397:2007.
10. Quasney M.W., Bronstein D.E., Cantor R.M., Zhang Q., Stroupe C., Shike H., et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 2001, 49:686-690.
11. Ahn S.Y., Jang G.C., Shin J.S., Shin K.M., Kim D.S. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003, 44:1021-1026.
12. Arj-Ong S., Thakkinstian A., McEvoy M., Attia J. A systematic review and meta-analysis of tumor necrosis factor alpha-308 polymorphism and Kawasaki disease. Pediatr Int 2010, 52:527-532.
13. Nickerson D.A., Tobe V.O., Taylor S.L. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997, 25:2745-2751.
14. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., et al. TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003, 31:374-378.
15. Chekmenev D.S., Haid C., Kel A.E. P-Match: Transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res 2005, 1:33. W432-7(Web Server issue):W432-7.
16. Ulmer A.J., Scholz W., Ernst M., Brandt E., Flad H.D. Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology 1984, 166:238-250.
17. Stephens M., Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169.
18. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
19. Cowles C.R., Hirschhorn J.N., Altshuler D., Lander E.S. Detection of regulatory variation in mouse genes. Nat Genet 2002, 32:432-437.
20. Rockman M.V., Wray G.A. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002, 19:1991-2004.
21. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998, 160:943-952.
22. Matsubara T., Ichiyama T., Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 2005, 141:381-387.
23. Yeung R.S. Pathogenesis and treatment of Kawasaki's disease. Curr Opin Rheumatol 2005, 17:617-623.
24. Furukawa S., Matsubara T., Umezawa Y., Okumura K., Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 1994, 124:721-725.
25. Burns J.C., Mason W.H., Hauger S.B., Janai H., Bastian J.F., Wohrley J.D., et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005, 146:662-667.
26. Chen G., Goeddel D.V. TNF-R1 signaling: A beautiful pathway. Science 2002, 296:1634-1635.
27. Aderka D., Engelmann H., Shemer-Avni Y., Hornik V., Galil A., Sarov B., et al. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992, 11:157-159.
28. Gupta R., Sharma S.C., Das S.N. Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 2008, 44:455-463.
29. Gordon A.C., Lagan A.L., Aganna E., Cheung L., Peters C.J., McDermott M.F., et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: A prospective multicentre study. Genes Immun 2004, 5:631-640.
30. Nishimura M., Obayashi H., Mizuta I., Hara H., Adachi T., Ohta M., et al. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 2003, 64:302-309.
31. Pitts S.A., Olomolaiye O.O., Elson C.J., Westacott C.I., Bidwell J.L. Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I (p55) gene. Eur J Immunogenet 1998, 25:271-272. [CrossRef].
32. Cheung Y.F., Huang G.Y., Chen S.B., Liu X.Q., Xi L., Liang X.C., et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 2008, 122:e608-e614.